Moreover, PTX3 inhibits the FGF-induced mitogenic, angiogenic, and tumorigenic potential in steroid hormones-regulated tumors [40], prostate cancer cells [41] and breast cancer [42]. The gene discussed is PTX3; the disease is breast cancer.